According to Global Blue Group's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.25628. At the end of 2023 the company had a P/S ratio of 2.16.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.16 | -32.34% |
2022 | 3.19 | -68.79% |
2021 | 10.2 | -40.29% |
2020 | 17.1 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.90 | 72.84% | ๐บ๐ธ USA |
Medtronic MDT | 3.31 | 46.54% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 7.50 | 232.29% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.62 | 282.09% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.20 | 174.76% | ๐บ๐ธ USA |